Simultaneous Pancreas–Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages

further validation and International collaborations that completeness of 86 registry data with the granularity of electronic health records provide a more comprehensive 87 picture of outcomes. Only through such integrated approaches will it be possible to determine whether 88 the metabolic advantage of simultaneous transplantation ultimately translates into reduced vascular 89 complications, preserved organ function, and better long-term health.The debate between simultaneous pancreas-kidney transplantation and kidney transplant alone is 91 therefore not settled but reframed. The survival benefits once attributed to the combined procedure is 92 less clear under modern analytic methods, yet its metabolic superiority remains unquestionable. More 93 and better evidence is required to fully understand how these dimensions balance over the decades of 94 life after transplantation. Until then, the value of simultaneous transplantation should be appreciated 95 not only through survival curves but also through its potential to transform the daily lives of carefully 96 selected patients.

Authors

Institutions

Publication Details

Journal
Transplant International
Published
2025-12-30
DOI
https://doi.org/10.3389/ti.2025.15708
Citations
1
Primary Topic
Renal Transplantation Outcomes and Treatments
Type
article
Field-Weighted Citation Impact
1.99
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Simultaneous Pancreas–Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages

LORENZO PIEMONTI
1 citations
Transplant International
Renal Transplantation Outcomes and Treatments
1.99
article

Simultaneous Pancreas–Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages

LORENZO PIEMONTI
article en
1 citations

Abstract

further validation and International collaborations that completeness of 86 registry data with the granularity of electronic health records provide a more comprehensive 87 picture of outcomes. Only through such integrated approaches will it be possible to determine whether 88 the metabolic advantage of simultaneous transplantation ultimately translates into reduced vascular 89 complications, preserved organ function, and better long-term health.The debate between simultaneous pancreas-kidney transplantation and kidney transplant alone is 91 therefore not settled but reframed. The survival benefits once attributed to the combined procedure is 92 less clear under modern analytic methods, yet its metabolic superiority remains unquestionable. More 93 and better evidence is required to fully understand how these dimensions balance over the decades of 94 life after transplantation. Until then, the value of simultaneous transplantation should be appreciated 95 not only through survival curves but also through its potential to transform the daily lives of carefully 96 selected patients.

Transplant InternationalVol. 38
Vita-Salute San Raffaele University (IT), IRCCS Ospedale San Raffaele (IT)
Partnerships for the goals
Openalex Percentile: Top 10%
Renal Transplantation Outcomes and Treatments
1.99
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Simultaneous Pancreas–Kidney Transplantation versus Kidney Alone: Interpreting Neutral Survival and Persistent Metabolic Advantages — LORENZO PIEMONTI · Transplant International (2025) | TGRS Research Map | TGRS